leisure time -WSS

leisure time

author：Wikipedia 2025-09-06 04:14:11 - browse：92289

The Federal Trade Commission office glows softly inside, contrasting with the darkness outside — coverage from STAT — Adobe

Over the past two decades, hundreds of hospital mergers have escaped federal antitrust scrutiny and led to both higher prices and less competition, a new study shows.

But the study’s authors, and other researchers, believe the Federal Trade Commission’s hands often are tied. The agency simply doesn’t have enough money or people to crack down on all anticompetitive hospital deals, and some state laws shield hospital mergers from federal review completely.

“The resources available are just not commensurate with what the agency needs,” said Zack Cooper, an associate professor of health policy and economics at Yale University and one of the co-authors of the study. “This isn’t a story of the FTC not knowing what to do. I actually think they really know, very clearly, what to do. It’s a lack of resources, person power, and potentially willingness to do it.”

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Drug repurposing or repositioning? The language matters
Next article： Study: Hearing aids may slow cognitive decline in those at risk

WSS

Israeli protesters block highways, train stations as Netanyahu moves ahead with judicial overhaul

Study: Hearing aids may slow cognitive decline in those at risk

Medicare drug price negotiation hearing pits pharma v Biden admin

Johnson & Johnson sues to stop Medicare negotiation

Britain’s MI6 chief says his spies are using AI to disrupt flow of weapons to Russia

Longer MASH drug regimen improved liver, Akero study finds

leisure time

leisure time

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Wikipedia

United colonoscopy coverage change 'may cost lives,' doctors say

Readout Newsletter: BridgeBio, Akero, and human embryo models

Cancer drug shortages should be causing more outrage

Fetal cell organoids grown from amniotic fluid, study finds

Jerome Adams on the need for new antivirals for Covid

For AI in health care standards, federal regulators join with industry group

FDA approval of Sarepta Duchenne genetic therapy gives me hope

$1 billion proposal to grow Boston, Massachusetts biotech

Bright Health sells Medicare Advantage business to Molina

Florida health officials providing scant details on measles cases

focus

Biden's 'march

Streamlined flu vaccines recommended by FDA advisory panel

Ancient Greek ideas underpin modern concepts of pregnancy

Twill hunts for pharma partner to market its depression app

Immune cells and nerve overgrowth may explain recurring UTI pain

knowledge

leisure time

explore

hotspot